These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
351 related items for PubMed ID: 25998996
1. Transarterial chemoembolization for hepatocellular carcinoma: An old method, now flavor of the day. Boulin M, Delhom E, Pierredon-Foulongne MA, Cercueil JP, Guiu B. Diagn Interv Imaging; 2015 Jun; 96(6):607-15. PubMed ID: 25998996 [Abstract] [Full Text] [Related]
3. Transarterial administration of integrin inhibitor loaded nanoparticles combined with transarterial chemoembolization for treating hepatocellular carcinoma in a rat model. Qian J, Oppermann E, Tran A, Imlau U, Qian K, Vogl TJ. World J Gastroenterol; 2016 Jun 07; 22(21):5042-9. PubMed ID: 27275096 [Abstract] [Full Text] [Related]
4. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease. Fidelman N, Kerlan RK. AJR Am J Roentgenol; 2015 Oct 07; 205(4):742-52. PubMed ID: 26397322 [Abstract] [Full Text] [Related]
7. Development of Conventional Transarterial Chemoembolization for Hepatocellular Carcinomas in Japan: Historical, Strategic, and Technical Review. Horikawa M, Miyayama S, Irie T, Kaji T, Arai Y. AJR Am J Roentgenol; 2015 Oct 07; 205(4):764-73. PubMed ID: 26397324 [Abstract] [Full Text] [Related]
12. Safety and efficacy of 70-150 μm and 100-300 μm drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma. Deipolyi AR, Oklu R, Al-Ansari S, Zhu AX, Goyal L, Ganguli S. J Vasc Interv Radiol; 2015 Apr 07; 26(4):516-22. PubMed ID: 25704226 [Abstract] [Full Text] [Related]
13. Improved stability of lipiodol-drug emulsion for transarterial chemoembolisation of hepatocellular carcinoma results in improved pharmacokinetic profile: Proof of concept using idarubicin. Boulin M, Schmitt A, Delhom E, Cercueil JP, Wendremaire M, Imbs DC, Fohlen A, Panaro F, Herrero A, Denys A, Guiu B. Eur Radiol; 2016 Feb 07; 26(2):601-9. PubMed ID: 26060065 [Abstract] [Full Text] [Related]
17. Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma. Kim DY, Ryu HJ, Choi JY, Park JY, Lee DY, Kim BK, Kim SU, Ahn SH, Chon CY, Han KH. Aliment Pharmacol Ther; 2012 Jun 07; 35(11):1343-50. PubMed ID: 22486716 [Abstract] [Full Text] [Related]
19. Transarterial chemoembolization of hepatocellular carcinoma in a rat model: the effect of additional injection of survivin siRNA to the treatment protocol. Vogl TJ, Oppermann E, Qian J, Imlau U, Tran A, Hamidavi Y, Korkusuz H, Bechstein WO, Nour-Eldin NE, Gruber-Rouh T, Hammerstingl R, Naguib NN. BMC Cancer; 2016 May 23; 16():325. PubMed ID: 27215551 [Abstract] [Full Text] [Related]
20. Long-term outcome of transcatheter subsegmental and segmental arterial chemoemobolization using lipiodol for hepatocellular carcinoma. Takaki S, Sakaguchi H, Anai H, Tanaka T, Yamamoto K, Morimoto K, Nishiofuku H, Inoue M, Sueyoshi S, Nagata T, Hidaka T, Uchida H, Kichikawa K. Cardiovasc Intervent Radiol; 2012 Jun 23; 35(3):544-54. PubMed ID: 21739345 [Abstract] [Full Text] [Related] Page: [Next] [New Search]